Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

0(0%)

Results Posted

60%(3 trials)

Terminated

1(14%)

Phase Distribution

Ph phase_2

43%

Ph phase_1

29%

Ph phase_3

14%

Ph phase_4

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

2(28.6%)

Phase 2Efficacy & side effects

3(42.9%)

Phase 3Large-scale testing

1(14.3%)

Phase 4Post-market surveillance

1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Terminated(1)

Other(1)

Detailed Status

Completed5

unknown1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

Phase 4

Trials by Phase

Phase 12 (28.6%)

Phase 23 (42.9%)

Phase 31 (14.3%)

Phase 41 (14.3%)

Trials by Status

completed571%

unknown114%

terminated114%

Recent Activity

0 active trials

Showing 5 of 7

unknownphase_3

Phase III Clinical Study of Azvudine in Hiv-infected Treatment Naive Patients

NCT04303598

terminatedphase_2

Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults

NCT02415595

completedphase_2

Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART

NCT01903031

completedphase_2

A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen

NCT01714414

completedphase_1

Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.

NCT01565889

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT04303598Phase 3

Phase III Clinical Study of Azvudine in Hiv-infected Treatment Naive Patients

Unknown

NCT02415595Phase 2

Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults

Terminated

NCT01903031Phase 2

Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART

Completed

NCT01714414Phase 2

A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen

Completed

NCT01565889Phase 1

Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.

Completed

NCT02253823Phase 1

Multiple Dose Comparison of the Effect of Two Dose Combinations of Tipranavir/Ritonavir (TPV/RTV), on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) in Healthy Adult Volunteers

Completed

NCT00978237Phase 4

Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7